NEFROPROTECTIVE EFFECTS OF ACTOVEGIN IN PATIENTS WITH DIABETIC NEPHROPATHY
Abstract
Apoptosis, programmed cell death, regarded as one of the main mechanisms of glomerulosclerosis in diabetic nephropathy (DN).
The aim of the present researchto study the effects of actovegin on cell apoptosis in patients with DN. Materials and methods: we examined 80 type 2 diabetic patients with DN I - IVstages and 10 healthy subjects. CD95+cells number was evaluated by indirect immunohis tochemistry.Results: CD95+ - cells number in the peripheral blood of patients with DN was significantly higher than in healthy donors. The additional actovegin treatment was accompanied by a significant decrease of the investigated parameter when compared with the base therapy.
Downloads
References
Алгоритмы специализированной медицинской помощи больным сахарным диабетом [Текст] : клинические рекомендации / Дедов И. И. Шестаковой. М. В. [и др.] ; под общ. ред. Дедова И. И., Шестаковой. М. В. - 6 - е изд. - М. : ООО «Информполиграф», 2013. - 119 с.
Строков И. А. Актовегин: механизмы действия и эффективность при неврологических осложнениях сахарного диабета / Строков И. А., Федорова О. С., Фокина А. С. [и др.] // Нервные болезни. – 2012. – № 3. – С. 21 - 27.
Топчій 1.1. Застосування резвератролу при лікуванні діабетичної нефропатії / Топчій І. І., Денисенко В.П., Щенявська О. М., Мазій В. В., Бондар Т. М.. // Кровообіг та гемостаз. – 2012. – № 1 - 2. – C. 39 - 44.
Шестакова М. В. Сахарный диабет и хроническая болезнь почек: достижения, нерешенные проблемы и перспективы лечения / Шестакова М. В., Шамхалова М. Ш., Ярек - Мартынова И. Я. [и др.] // Сахарный діабет. – 2011. – № 1. – С. 81 - 88.
Bo Wang Transforming growth factor - p1 - mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let - 7b / Bo Wang, Jay C Jha, Shinji Hagiwara [et al.] // Kidney International. – 2014. – V. 85. – P. 352 - 361.
Buchmayer F. Actovegin: a biological drug for more than 5 decades / Buchmayer F., Pleiner J., Elmlinger M.W. [et al.] // Actovegin®: Wien Med Wochenschr. – 2011. - V. 161. - P. 80 - 88.
Giordano С. Defective expression of the apoptosis - inducing CD95 (Fas/APO - 1) molecule on Т and B - cells in 1DDM / Giordano С., De Maria R., Stassi G., Todaro M., [et al.] // Diabetologia. - 2010. - V. 38. - № 12. - P.1449 - 1454.
Huang Y. Prehypertension and the risk of stroke: a metaanalysis / Huang Y., Cai X., Li Y. [et al.] // Neurology. - 2014. - V. 82(13). - P. 1153 - 1161.
Kumar Sharma. Obesity, oxidative stress, and fibrosis in chronic kidney disease / Kumar Sharma // Kidney International Supplements. - 2014. - N. 4. - P.113 - 117.
Machicao F. Pleiotropic neuroprotective and metabolic effects of Actovegin’s mode of action / Machicao F., Muresanu D. F., Hundsberger H. [et al.] // J Neurol Sci. - 2012. - V. 322. - P. 222 - 227.
Manoocher Soleimani. Insulin resistence and hypertension: new insights / Manoocher Soleimani // Kidney International. - 2015. - V. 87 - I.3. - Р. 497 - 499.
Marpadga A Reddy, Putta Sumanth, Linda Lanting et al. Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice / Manoocher Soleimani // Kidney International. - 2014. - V. 85. - P. 362 - 373.
Matsumoro К. Induction apoptosis in human eosinophils by anti - Fas antibody treatment in vitro / Matsumoro К., Schleimer R. P., Suito [et. al.] // Blood. – 2012. – V. 86. - P. 1437 - 1443.
Matthias Mack. Origin of myofibroblasts and cellular events triggering fibrosis / Matthias Mack, Motoko Yanagita // Kidney International. – 2015. – V. 87. – P. 297 - 307.
Rognant N. Performance of the chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in diabetic patients / Rognant N., Lemoine S., Laville M., [et al.] // Diabetes Care. – 2011. – V. 34. – P. 1320 - 1322.
Sanchez - Nino MD. New paradigms in cell death in human diabetic nephropathy / Sanchez - Ni o MD., BenitoMartin A., Ortiz A. // Kidney International. – 2010. – V. 78(8). – P. 737 - 744.
Verzola D. Apoptosis in the kidneys of patients with type II diabetic nephropathy / Verzola D., Gandolfo M.T., Ferrario F. Rastaldi M.P., Villaggio B., Gianiorio F. // Kidney International. – 2007. – V. 72. – Р.1262 - 1272.
Wagener F. A. The role of reactive oxygen species in apoptosis of the diabetic kidney / Wagener F. A., Dekker D., Berden J. H., Scharstuhl A., Van der Vlag J
